Silymarin/Milk Thistle: University of Washington laboratory study confirms this traditional botanical’s anti-inflammatory, anti-hepatitis C activity, and suggests its usefulness as an adjunct approach in managing chronic hepatitis C

In the May 2007 issue of Gastroenterology, investigators from the University of Washington/Seattle reported on a study of a standardized extract of milk thistle (silymarin), the botanical with a long tradition of use to treat liver disease. They concluded: “The data indicate that silymarin exerts anti-inflammatory and antiviral effects, and suggest that complementary and alternative medicine-based approaches may assist in the management of patients with chronic hepatitis C.”

OK–no big surprising news here. But it’s always nice to see more evidence and more detail about how and why a traditional botanical works effectively!

Citation: SJ Polyak, C Morishima, MC Shuhart, and others. Inhibition of T-cell inflammatory cytokines, hepatocyte NF-kappa B signaling, and HCV infection by standardized silymarin. Gastroenterology 132(5): 1925-1936. May 2007.


Leave a Reply

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s